Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.9287
-0.0537-5.47%
Last update: Oct 22, 9:29 AM
$0.9500
-0.0324-3.3%
BioCardia Inc (BCDA) Stock Price, Quote, News & History
BCDANASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BioCardia (NASDAQ:BCDA) through any online brokerage.
Other companies in BioCardia’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
BioCardia has a consensus price target of $25.00.
The stock price for BioCardia (NASDAQ: BCDA) is $0.95 last updated October 22, 2026 at 9:29 AM EDT.
There are no upcoming dividends for BioCardia.
BioCardia does not have any upcoming earnings scheduled.
There is no upcoming split for BioCardia.
BioCardia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
